丁丙诺啡：与美沙酮相比，是孕期阿片类物质使用障碍治疗的更佳选择。
Buprenorphine: A Better Option for Opioid Use Disorder Treatment in Pregnancy Compared to Methadone.
作者信息
Sanford Bailey, Espinoza Alejandra, Eniola Kehinde
机构信息
From the Cone Health Family Medicine, Greensboro, NC (BS); Cone Health Family Medicine, Greensboro, North Carolina (AE); Cone Health Family Medicine, Greensboro, NC (KE).
出版信息
J Am Board Fam Med. 2025 Jan-Feb;38(1):188-191. doi: 10.3122/jabfm.2024.240349R0.
Abstract
Buprenorphine, rather than methadone, should be considered the preferred first-line therapy for opioid use disorder in pregnancy due to its more favorable neonatal outcomes..
摘要
由于丁丙诺啡对新生儿结局更有利，在孕期阿片类物质使用障碍的治疗中，应将其而非美沙酮视为首选的一线治疗药物。
相似文献
1
Buprenorphine: A Better Option for Opioid Use Disorder Treatment in Pregnancy Compared to Methadone.丁丙诺啡：与美沙酮相比，是孕期阿片类物质使用障碍治疗的更佳选择。
J Am Board Fam Med. 2025 Jan-Feb;38(1):188-191. doi: 10.3122/jabfm.2024.240349R0.
2
Use of naltrexone in treating opioid use disorder in pregnancy.纳曲酮在治疗妊娠期阿片类药物使用障碍中的应用。
Am J Obstet Gynecol. 2020 Jan;222(1):83.e1-83.e8. doi: 10.1016/j.ajog.2019.07.037. Epub 2019 Jul 31.
3
Pharmacological treatment of opioid use disorder in pregnancy.妊娠期阿片类药物使用障碍的药物治疗。
Semin Perinatol. 2019 Apr;43(3):141-148. doi: 10.1053/j.semperi.2019.01.003. Epub 2019 Jan 21.
4
Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.美沙酮、丁丙诺啡和纳曲酮用于治疗孕妇阿片类物质使用障碍
Pharmacotherapy. 2017 Jul;37(7):824-839. doi: 10.1002/phar.1958. Epub 2017 Jul 2.
5
Chronic opioid use during pregnancy: maternal and fetal implications.孕期慢性阿片类药物使用：对母体和胎儿的影响。
Clin Perinatol. 2013 Sep;40(3):337-50. doi: 10.1016/j.clp.2013.05.015. Epub 2013 Jul 4.
6
Dual dilemma-should naltrexone be used in the treatment of opioid-dependent pregnant women?双重困境——纳曲酮是否应用于治疗阿片类药物依赖的孕妇？
Addiction. 2013 Feb;108(2):249-50. doi: 10.1111/j.1360-0443.2012.03883.x.
7
Buprenorphine and methadone for opioid addiction during pregnancy.孕期阿片类药物成瘾的丁丙诺啡和美沙酮治疗。
Obstet Gynecol Clin North Am. 2014 Jun;41(2):241-53. doi: 10.1016/j.ogc.2014.02.005. Epub 2014 Apr 3.
8
Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.胎儿暴露于美沙酮和丁丙诺啡后的新生儿结局：来自捷克共和国和挪威的国家登记研究。
Addiction. 2018 Jul;113(7):1286-1294. doi: 10.1111/add.14192. Epub 2018 Mar 24.
9
Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study.美沙酮与丁丙诺啡用于妊娠阿片类药物依赖妇女：一项前瞻性多中心研究。
Eur J Clin Pharmacol. 2011 Oct;67(10):1053-9. doi: 10.1007/s00228-011-1049-9. Epub 2011 May 3.
10
Methadone and buprenorphine for the management of opioid dependence in pregnancy.美沙酮和丁丙诺啡用于妊娠期间阿片类药物依赖的管理。
Drugs. 2012 Apr 16;72(6):747-57. doi: 10.2165/11632820-000000000-00000.
本文引用的文献
1
The Priority Updates from the Research Literature (PURLs) Methodology.研究文献的优先更新（PURLs）方法
J Am Board Fam Med. 2024 Oct 25;37(4):799-802. doi: 10.3122/jabfm.2024.230410R0.
2
Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl.芬太尼时代阿片类药物使用障碍患者的丁丙诺啡剂量和停药时间。
JAMA Netw Open. 2023 Sep 5;6(9):e2334540. doi: 10.1001/jamanetworkopen.2023.34540.
3
Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study.阿片类物质使用障碍孕妇接受阿片类激动剂治疗的安全性比较：一项基于人群的研究。
Drug Saf. 2023 Mar;46(3):257-271. doi: 10.1007/s40264-022-01267-z. Epub 2023 Jan 16.
4
Neonatal Outcomes after Use of Buprenorphine during Pregnancy.孕期使用丁丙诺啡后的新生儿结局
N Engl J Med. 2022 Dec 1;387(22):2085-2086. doi: 10.1056/NEJMe2212967.
5
Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy.布比卡因与美沙酮治疗妊娠合并阿片类药物使用障碍。
N Engl J Med. 2022 Dec 1;387(22):2033-2044. doi: 10.1056/NEJMoa2203318.
6
To use or not to use buprenorphine for illegally manufactured fentanyl.是否使用丁丙诺啡治疗非法制造的芬太尼。
Fam Pract. 2023 Mar 28;40(2):428-430. doi: 10.1093/fampra/cmac098.
7
Buprenorphine Compared with Methadone in Pregnancy: A Systematic Review and Meta-Analysis.孕期丁丙诺啡与美沙酮的比较：一项系统评价与荟萃分析。
Subst Use Misuse. 2022;57(9):1400-1416. doi: 10.1080/10826084.2022.2083174. Epub 2022 Jun 25.
8
Implications of Increased Access to Buprenorphine for Medical Providers in Rural Areas: A Review of the Literature and Future Directions.农村地区医疗服务提供者获取丁丙诺啡机会增加的影响：文献综述与未来方向
Cureus. 2021 Nov 24;13(11):e19870. doi: 10.7759/cureus.19870. eCollection 2021 Nov.
9
The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15-year retrospective cohort study.患者、治疗和处方医生特征对阿片类激动剂治疗保留率的影响：一项长达 15 年的回顾性队列研究。
Addiction. 2021 Nov;116(11):3139-3152. doi: 10.1111/add.15514. Epub 2021 May 12.
10
Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010-2017.美国 2010-2017 年的新生儿戒断综合征和与母亲阿片类药物相关的诊断。
JAMA. 2021 Jan 12;325(2):146-155. doi: 10.1001/jama.2020.24991.
Zotero 插件